Search results

Order by most recent / most popular / relevance

Results: 1-10 of 207

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Bereskin & Parr LLP
-
Canada
-
May 9 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

Bereskin & Parr LLP
-
Canada
-
April 30 2013

On October 9, 2012, six retailers, BEST BUY, Costco, GAP, OLD NAVY, GUESS? And WAL-MART, filed a motion in the Superior Court of Quebec seeking a

Top ten things for trademark owners to know about Canada’s new Combating Counterfeit Products Act

Bereskin & Parr LLP
-
Canada
-
April 17 2013

On March 1, 2013, Canada's Parliament gave first reading to Bill C-56 (the "Bill"), entitled the Combating Counterfeit Products Act (the "CCPA"

The Thymes they are a changin’

Bereskin & Parr LLP
-
Canada
-
April 17 2013

Canadian trademark applications must identify a filing ground, the most common of which are (1) use in Canada; (2) proposed use in Canada; and (3

Use issues in Canada

Bereskin & Parr LLP
-
Canada
-
April 17 2013

For decades, Canadian trademark law has focused on the importance of ensuring that trademark use by licensees does not adversely affect trademark

Is e-commerce changing the definition of trademark “use” in Canada?

Bereskin & Parr LLP
-
Canada
-
April 17 2013

Several recent decisions of the Canadian courts and the Trade-marks Opposition Board (the "Board") analyze the impact of e-commerce on claims of

Securing IP in stem cells

Bereskin & Parr LLP
-
Canada, USA
-
April 12 2013

Stem cells are at the centre of research into regenerative medicine. They have the ability to continuously produce newly differentiated cells and

Gilead leave to appeal to Supreme Court of Canada dismissed re: FCA decision not to list patent on register due to lack of product specificity under PM(NOC) regulations

Bereskin & Parr LLP
-
Canada
-
March 21 2013

In Gilead Sciences Canada Inc. v. Canada (Minister of Health), 2012 FCA 254, the Federal Court of Appeal (FCA) dismissed Gilead's appeal of the

Leave to appeal to Supreme Court of Canada denied to Philip Morris in trademark dispute

Bereskin & Parr LLP
-
Canada
-
March 21 2013

The Supreme Court of Canada denied leave to appeal to Philip Morris from the Federal Court of Appeal's decision in Marlboro Canada Limited, Imperial

next >

Search results

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Retailers’ challenge of the OQLF’s interpretation of the Charter of the French Language

Top ten things for trademark owners to know about Canada’s new Combating Counterfeit Products Act

The Thymes they are a changin’

Use issues in Canada

Is e-commerce changing the definition of trademark “use” in Canada?

Securing IP in stem cells

Gilead leave to appeal to Supreme Court of Canada dismissed re: FCA decision not to list patent on register due to lack of product specificity under PM(NOC) regulations

Leave to appeal to Supreme Court of Canada denied to Philip Morris in trademark dispute

Current Search

Suggested Facets

Author

Jurisdiction

Workarea